Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: A randomised controlled trial

Lancet Oncology

Volumn 6, Issue 5, 2005, Pages 295-300

  Perdonà, Sisto ^a   Autorino, Riccardo ^b   De Placido, Sabino ^c   D'Armiento, Massimo ^b   Gallo, Antonio ^a   Damiano, Rocco ^d   Pingitore, Domenico ^e   Gallo, Luigi ^a   De Sio, Marco ^b   Bianco, Angelo Raffaele ^c   Di Lorenzo, Giuseppe ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^e PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; BICALUTAMIDE; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN; TAMOXIFEN CITRATE;

ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; BEAM THERAPY; BONE MARROW TOXICITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTRON THERAPY; ERYTHEMA; FEVER; GYNECOMASTIA; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE BREAST; MASTALGIA; MONOTHERAPY; MULTICENTER STUDY; NEUROLOGIC DISEASE; NIPPLE; PRIORITY JOURNAL; PROSTATE CANCER; PRURITUS; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SKIN IRRITATION; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESTROGEN ANTAGONISTS; GYNECOMASTIA; HUMANS; MALE; MIDDLE AGED; PAIN; PROSTATIC NEOPLASMS; TAMOXIFEN;

EID: 20944447546     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70103-0     Document Type: Article

References (21)

1. GJCM Kolvenbag The prostate cancer continuum: The role of bicalutamide The Prostate Journal 3 2001 2-13
2. P Carroll Rising PSA after a radical treatment Eur Urol 40 suppl 2 2001 9-16
3. CL Amling ML Blute EJ Bergstralh et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years J Urol 164 2000 101-105
4. P Iversen CJ Tyrrell AV Kaisary Bicalutamide 150 mg monotherapy compared with castration in patients with non-metastatic locally advanced prostate cancer: 6·3 years' follow-up J Urol 164 2000 1579-1582
5. F Boccardo A Rubagotti M Barichello et al. Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients. Results of an Italian prostate cancer project (PONCAP) study J Clin Oncol 17 1999 2027-2038
6. C Chatelain RO Fourcade J Delchambre Bicalutamide versus combined androgen blockade: Open French multicentre trial in patients with metastatic prostate cancer Br J Urol 80 1997 283
7. MP Wirth WA See DG McLeod et al. Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: Results from the second analysis of early prostate cancer program at median follow-up of 5·4 years J Urol 172 2004 1865-1870
8. DG McLeod P Iversen Gynaecomastia in patients with prostate cancer: A review of treatment options Urology 56 2000 713-720
9. AP Dicker The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy Lancet Oncol 4 2003 30-36
10. NK Aaronson S Ahmedzai B Bergman et al. The European Organization for Research and Treatment of cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365-376
11. P Armitage G Berry Statistical Methods in Medical Research 3rd edn. 1994 Blackwell Oxford
12. D Prezioso G Piccirillo R Galasso et al. Gynaecomastia due to hormone therapy for advanced prostate cancer: A report of ten surgically treated cases and a review of treatment options Tumori 90 2004 410-415
13. F Boccardo A Rubagotti M Battaglia et al. Evaluation of tamoxifen and anastrozole in the prevention of gynaecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer J Clin Oncol 23 2005 808-815
14. D Saltzstein P Sieber T Morris J Gallo Prevention and management of bicalutamide induced gynaecomastia and breast pain: Randomized endocrinologic and clinical studies with tamoxifen and anastrozole Prostate Cancer Prostatic Dis 8 2005 75-83
15. CJ Tyrrel H Payne TLJ Tammela et al. Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia Int J Radiat Biol Phys 60 2004 476-483
16. Van Poppel H, Tyrrell CJ, Haustermans K, et al. Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer. Eur Urol Published online Dec 30, 2004; DOI:10.1016/j.eururo.2004.12.003
17. AC Eaton A Makris A Makris Once weekly tamoxifen in the prevention of gynaecomastia and breast pain secondary to bicalutamide therapy J Urol 171 2004 282
18. A Widmark SD Fossa P Lundmo et al. Does prophylactic breast irradiation prevent antiandrogen-induced gynaecomastia? Evaluation of 253 patients in the Randomized Scandinavian Trial SPCG-7/SFUO-3 Urology 61 2003 145-151
19. MC Joiner The linear-quadratic approach to fractionation In: GC Steel (Eds.) Basic clinical radiobiology 1993 Edward Arnold London 55-64
20. I Kunkler Adjuvant irradiation for breast cancer BMJ 320 2000 1485-1489
21. C Abson Radiotherapy for benign disease Br J Radiol 73 2000 121-125